A328130 Share Price Performance
₩38,150.00
-10050.00 (-20.85%)
Price ₩38,150.00
Share Pricen/a
Some Confidence Is Lacking In Lunit Inc.'s (KOSDAQ:328130) P/S
Oct 31
Lunit Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
A328130 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Lunit Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -4.04k
- 100.00%
- -159.90%
- 58.6%
About A328130
- Founded
- 2013
- Employees
- 298
- CEO
- WebsiteView website
Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea. It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer. The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations and with Agilent Technologies Inc. to create advanced solutions that meet the demand of novel and complex biomarker assays in drug development. Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.